London, 20th May 2024: Oxford Endovascular today announces the successful completion of an £8 million Series A+ funding round. The MedTech start-up, founded in […]

Oxford Endovascular is proud to be selected as one of the Top 50 start-ups in the MedTech Innovator competition: https://www.businesswire.com/news/home/20220607005636/en/MedTech-Innovator-Announces-Top-50-Startups-Selected-for-the-2022-Cohort-in-Tenth-Year-of-World%E2%80%99s-Largest-MedTech-Accelerator-Program

Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company […]

Press Release: Oxford, UK, 14th November 2020.   Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients […]

Following extensive due diligence by medical, industry, and investor experts, Oxford Endovascular is selected as one of Europe’s top start-ups to be […]

This kick starts the company’s next fundraise to take it to first in human clinical data. See the RESI landing page for […]

  ‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’   This project […]

Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) […]

On Monday, November 12th at 1600, Oxford Endovascular appeared live on ‘The Series A Hour with Match Capital’. This second series of […]

The company successfully raises £2.5M to continue its development work and progression through its animal studies over 2018/2019 in advance of making […]